Us2.ca vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Us2.ai
VS
by RhythmScience

AI Verdict

Us2.ca specializes in fully automating echocardiography analysis, providing rapid, structured reports from imaging data. In contrast, Rhythm360 focuses on unifying and analyzing cardiac monitoring data from various devices to manage conditions like hypertension and heart failure and reduce alert fatigue. Therefore, Us2.ca is ideal for optimizing echo lab workflows, while Rhythm360 is better suited for practices managing extensive remote cardiac monitoring data.

Choose Us2.ca if…

Choose Us2.ai if your cardiology department or imaging lab seeks to fully automate and standardize echocardiography analysis, aiming to significantly enhance diagnostic accuracy and workflow efficiency. This tool is ideal for facilities performing a high volume of echoes that require rapid, AI-powered disease detection and comprehensive, structured cardiac reporting directly integrated into existing systems.

View Us2.ca →

Choose Rhythm360 if…

Choose Rhythm360 if your practice manages a large cohort of patients with various remote cardiac monitoring devices and needs a unified platform to aggregate and interpret this data. This solution is best suited for organizations looking to reduce alert fatigue, leverage AI for actionable insights in rhythm and heart failure management, and automate CPT code documentation for remote patient monitoring services.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Us2.ca Rhythm360
Pricing Unknown Flexible pricing model that scales with clinic size and platform usage.
Deployment Vendor-neutral across GE, Philips, Siemens, Canon and handheld POCUS. Cloud-based SaaS platform
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Us2.ca Rhythm360
Product Name Us2.ca Rhythm360
Company Eko.Ai Pte Ltd. D/B/A Us2.Ai RhythmScience
Primary Function Fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports. Unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management.
Core Capability Fully automated echocardiography analysis (zero clicks) and real-time structured report generation. Vendor-neutral data aggregation and AI-driven alert triage.
EHR/EMR Integration Integration with EMR. Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity).

Videos

Demos, reviews, and walkthroughs featuring Us2.ca and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Us2.ai is an AI platform that fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports in seconds and aiding in the detection of diseases like Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension. Rhythm360, conversely, is an AI-powered integrated platform that unifies cardiac monitoring data from various devices to provide actionable insights for hypertension, heart failure, and rhythm management, aiming to reduce alert fatigue.
Us2.ai integrates with ultrasound devices, PACS, CVIS, and EMR systems, supporting HL7 and DICOM SR for structured report delivery. Rhythm360 offers bi-directional EHR integration with major systems such as Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, and GE Centricity via HL7, and includes a HIPAA-compliant mobile application for clinicians.
Us2.ai processes comprehensive cardiac structural and functional parameters from echocardiography, including 2D, Doppler, M-mode, and strain imaging, with zero-click analysis. Rhythm360 aggregates and normalizes cardiac monitoring data from various major OEM devices like Medtronic, Boston Scientific, Abbott, and Biotronik, using API, HL7, XML, and computer vision for PDF parsing.
Us2.ai is FDA-cleared and CE-marked, with additional regulatory approvals in multiple countries. Both Us2.ai and Rhythm360 are HIPAA compliant, and both companies offer a Business Associate Agreement (BAA) for US customers.
Us2.ai provides fully automated echocardiography analysis with zero clicks, real-time processing, and explainable AI with editable annotations, significantly reducing reporting time. Rhythm360 offers AI-driven alert triage to reduce alert fatigue and achieve 80% faster response times, automated CPT code documentation and billing, and optional 24/7/365 oversight by certified cardiac technicians.
AI Tool Finder
AI-powered search. Results may not be comprehensive.